2007
DOI: 10.1007/s00125-007-0790-1
|View full text |Cite
|
Sign up to set email alerts
|

Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance

Abstract: Insulin downregulates VLDL(1) secretion and increases VLDL(2) secretion in participants with low liver fat but fails to suppress VLDL(1) secretion in participants with high liver fat, resulting in overproduction of VLDL(1). Thus, liver fat is associated with lack of VLDL(1) suppression in response to insulin.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

12
131
0
2

Year Published

2008
2008
2018
2018

Publication Types

Select...
3
3
1

Relationship

0
7

Authors

Journals

citations
Cited by 167 publications
(145 citation statements)
references
References 48 publications
12
131
0
2
Order By: Relevance
“…However, studies have also shown an association between liver fat content and the postprandial increase in ApoB-100 [28,29], indicating that endogenous VLDL-TAG secretion may also contribute to postprandial lipaemia in type 2 diabetes. Despite the wide range of different tracers and kinetic models employed to study VLDL-TAG kinetics, results in healthy individuals have convincingly shown that acute experimental hyperinsulinaemia decreases hepatic production of VLDL-ApoB [12,14,[30][31][32][33] and VLDL-TAG [10,12,14,30,31], primarily through suppression of VLDL 1 (rather than VLDL 2 ) production [12,32,33]. Insulin-mediated suppression of VLDL-TAG secretion may partly be attributed to diminished hepatic NEFA delivery secondary to suppression of adipose tissue lipolysis [34].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…However, studies have also shown an association between liver fat content and the postprandial increase in ApoB-100 [28,29], indicating that endogenous VLDL-TAG secretion may also contribute to postprandial lipaemia in type 2 diabetes. Despite the wide range of different tracers and kinetic models employed to study VLDL-TAG kinetics, results in healthy individuals have convincingly shown that acute experimental hyperinsulinaemia decreases hepatic production of VLDL-ApoB [12,14,[30][31][32][33] and VLDL-TAG [10,12,14,30,31], primarily through suppression of VLDL 1 (rather than VLDL 2 ) production [12,32,33]. Insulin-mediated suppression of VLDL-TAG secretion may partly be attributed to diminished hepatic NEFA delivery secondary to suppression of adipose tissue lipolysis [34].…”
Section: Discussionmentioning
confidence: 99%
“…In contrast, acute hyperinsulinaemia leads to a rapid inhibition of hepatic VLDL-TAG secretion, as evidenced from data stemming from in vitro studies, animal models and human studies [6][7][8]10]. Some previous studies have shown that diabetic patients fail to downregulate secretion of large VLDL (VLDL 1 ) in an experimental setting with high-dose insulin infusion [11,12], whereas we reported a preserved suppressive effect of hyperinsulinaemia on VLDL-TAG secretion [7]. The impact of meal-induced hyperinsulinaemia, on the other hand, is less well understood.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Adiels et al [15] carried out a study into the suppression of hepatic VLDL1 secretion by insulin, and of particular use to us VLDL-TAG is measured. This secretion of VLDL1 relates in our model to the release of TAG from the liver; although the other types of lipoprotein are involved in TAG transport, VLDL1 is responsible for the majority of the flux through the insulin inhibited hepatic secretion pathway.…”
Section: Parameter Assessmentmentioning
confidence: 99%
“…Although it has been shown that there is a strong correlation between obesity and fatty liver disease [14] it is not known if fatty liver disease is the cause or effect of insulin resistance. It has been shown that post-prandial hepatic triglyceride release is higher in people with fatty liver disease than healthy people although the basal secretion rate is the same, indicating that it is not a higher fat presence in the liver which causes the increased output but rather insulin resistance [15].…”
Section: Introductionmentioning
confidence: 99%